{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:21:49Z","timestamp":1782739309682,"version":"3.54.5"},"reference-count":149,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurodegener. Dis. Manag."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.2217\/nmt.15.39","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T17:39:44Z","timestamp":1446226784000},"page":"445-462","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Benefits and Risks of Add-On Therapies for Alzheimer\u2019s Disease"],"prefix":"10.1080","volume":"5","author":[{"given":"Radoslaw","family":"Magierski","sequence":"first","affiliation":[{"name":"Department of Old Age Psychiatry & Psychotic Disorders Medical University of Lodz\r92\u2013216 Lodz\rCzechoslowacka Street 8\/10\rPoland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Sobow","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology Medical University of Lodz\rSterlinga Street 5\r91\u2013425\rLodz\rPoland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61570-6"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2012.11.003"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318293e2ce"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/852368"},{"issue":"3","key":"e_1_3_2_7_1","first-page":"235","article-title":"Caregivers of Alzheimer\u2019s patients and factors influencing institutionalization of loved ones: some considerations on existing literature","volume":"25","author":"Sansoni J","year":"2013","unstructured":"Sansoni J , AndersonKH, VaronaLM, VarelaG . Caregivers of Alzheimer\u2019s patients and factors influencing institutionalization of loved ones: some considerations on existing literature . Ann. Ig.25 ( 3 ), 235 \u2013 246 ( 2013 ).","journal-title":"Ann. Ig."},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2014.03.003"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/11599140-000000000-00000"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/11631830-000000000-00000"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40142-014-0034-x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.05.006"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.1491"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307719"},{"key":"e_1_3_2_15_1","article-title":"Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"6","author":"Ritchie C","year":"2014","unstructured":"Ritchie C , SmailagicN, Noel-StorrAHet al. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI) . Cochrane Database Syst. Rev.6, CD008782 ( 2014 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.01.041"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70178-3"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70090-0"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.07.004"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt269"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.883921"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-132690"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31825018f7"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.110190"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2013.03.002"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.05.004"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2010.01435.x"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-130845"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12191"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v4.i4.72"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1586\/ern.10.43"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1586\/ern.12.124"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.11.005"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-013-9398-z"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.04.037"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.118"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.08.007"},{"issue":"7","key":"e_1_3_2_41_1","first-page":"8S","article-title":"Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer\u2019s disease","volume":"46","author":"Geerts H","year":"2006","unstructured":"Geerts H , GrossbergGT . Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer\u2019s disease . J. Clin. Pharmacol.46 ( 7 Suppl. 1 ), 8S \u2013 16S ( 2006 ).","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00411-2"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200303000-00003"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D638"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12036"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0038-9"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-84"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-14-10"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0161-z"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/11599460-000000000-00000"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/0898264310381277"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S63756"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q589"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afs012"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-1992-z"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000350031"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-140759"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-184"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0170-6"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0143-3"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03450.x"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.3.317"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wad.0000213860.35355.d4"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wad.0000213859.35355.59"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000203151.17311.38"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000223333.42368.f1"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4074"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(04)80689-4"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00769.x"},{"issue":"5","key":"e_1_3_2_70_1","first-page":"258","article-title":"Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer\u2019s disease: results of a 12-week, open-label pilot study","volume":"8","author":"Riepe MW","year":"2006","unstructured":"Riepe MW , AdlerG, IbachB, WeinkaufB, GunayI, TracikF . Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer\u2019s disease: results of a 12-week, open-label pilot study . Prim. Care Companion J. Clin. Psychiatry.8 ( 5 ), 258 \u2013 263 ( 2006 ).","journal-title":"Prim. Care Companion J. Clin. Psychiatry."},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1159\/000100875"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200828060-00004"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2355"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903434914"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1159\/000366198"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412464718"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-143084"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S40682"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0077-7"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-132735"},{"issue":"2","key":"e_1_3_2_81_1","first-page":"2944","article-title":"Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer\u2019s disease","volume":"8","author":"Shao ZQ","year":"2015","unstructured":"Shao ZQ . Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer\u2019s disease . Int. J. Clin. Exp. Med.8 ( 2 ), 2944 \u2013 2948 ( 2015 ).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.10.015"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-012-0062-8"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106668"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1159\/000338236"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.582484"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1159\/000342927"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1159\/000210388"},{"issue":"6","key":"e_1_3_2_89_1","first-page":"665","article-title":"[Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia]","volume":"79","author":"Portela Romero M","year":"2005","unstructured":"Portela Romero M , Pombo RomeroJ, Bugar\u00edn Gonz\u00e1lezR, Tasende SoutoM, Represa VeigaS . [Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia] . Rev. Esp. Salud. Publica.79 ( 6 ), 665 \u2013 672 ( 2005 ).","journal-title":"Rev. Esp. Salud. Publica."},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720508783884576"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.343"},{"key":"e_1_3_2_92_1","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"3","author":"Birks J","year":"2006","unstructured":"Birks J . Cholinesterase inhibitors for Alzheimer\u2019s disease . Cochrane Database Syst. Rev.3, CD005593 ( 2006 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003154.pub5"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000032"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31815a9e10"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-131103"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2009.02200.x"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.130451"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-10-57"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.06.019"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31816653bc"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.158964"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu115"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1159\/000335156"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1483-y"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610215000654"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2012.01.002"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12707"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70146-2"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2516"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70194-0"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005158"},{"key":"e_1_3_2_113_1","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease","volume":"3","author":"Rolinski M","year":"2012","unstructured":"Rolinski M , FoxC, MaidmentI, McShaneR . Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease . Cochrane Database Syst. Rev.3, CD006504 ( 2012 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307659"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1159\/000088494"},{"key":"e_1_3_2_116_1","article-title":"Galantamine for vascular cognitive impairment","volume":"4","author":"Craig D","year":"2013","unstructured":"Craig D , BirksJ . Galantamine for vascular cognitive impairment . Cochrane Database Syst. Rev.4, CD004746 ( 2013 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_117_1","article-title":"Rivastigmine for vascular cognitive impairment","volume":"5","author":"Birks J","year":"2013","unstructured":"Birks J , McGuinnessB, CraigD . Rivastigmine for vascular cognitive impairment . Cochrane Database Syst. Rev.5, CD004744 ( 2013 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70195-3"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.11.095"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt201"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/427318"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.85"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.2165\/11597550-000000000-00000"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-12-230"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002854.pub3"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.01.014"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282834"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1510"},{"key":"e_1_3_2_129_1","article-title":"Statins for the treatment of dementia","volume":"7","author":"McGuinness B","year":"2014","unstructured":"McGuinness B , CraigD, BullockR, MaloufR, PassmoreP . Statins for the treatment of dementia . Cochrane Database Syst. Rev.7, CD007514 ( 2014 ).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00282"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-132741"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00147"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000138"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2014.01.003"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S65625"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2012.07.001"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.12488"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.12455"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt58"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afv044"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2012.12.001"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1317918110"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt213"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2013.07.017"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.03.016"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-050212-185535"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt96"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-014-0087-9"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt276"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-014-1250-1"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm3009458"}],"container-title":["Neurodegenerative Disease Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nmt.15.39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:47:43Z","timestamp":1716493663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nmt.15.39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.2217\/nmt.15.39"],"URL":"https:\/\/doi.org\/10.2217\/nmt.15.39","relation":{},"ISSN":["1758-2024","1758-2032"],"issn-type":[{"value":"1758-2024","type":"print"},{"value":"1758-2032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}